I rate Bio-Rad (NYSE:BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect.

The Franklin Small Cap Value Fund fared better than its benchmark for the first quarter of 2025. Click here to read the full ...

The White Lotus’ stays at No. 1 the week after its season ends, and ‘Black Mirror’ and ’The Handmaid’s Tale’ make solid ...

CBS closed the 2024-25 season with strong performers across linear and streaming, with the ratings providing insight into ...

LSU QB Garrett Nussmeier has a chance to be one of the best passers in the country this year. Here's what his 2024 passing chart reveals.

America’s Most-Watched Network… still is. Nielsen on Wednesday morning released its first full-season ranking of broadcast ...

April 9 -12: Trump’s disapproval rating stayed stagnant, at 53%, in the latest Quinnipiac University poll taken April 3-7 ...

The Four Seasons,” Netflix’s new comedy series from Tina Fey, debuted as the streamer’s most-watched TV title of the week of ...

Matt Maiocco breaks down the San Francisco 49ers' offensive depth chart after the team's 2025 NFL Draft selections.

Less than three months into his second term, Donald Trump has sparked global policy uncertainty. The US itself is at risk of ...

HYBE shares were up nearly 14% this week on its latest earnings report as music stocks rose again, including Universal Music, ...

We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Palo Alto Networks. This level of activity is out of the ...